Search
for
Sort by
Research 391–420 of 1000+
- Treatment of Hirsutism With Spironolactone
- The effects of two doses of spironolactone on serum androgens and anagen hair in hirsute women
- Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men
- A Novel Use of Spironolactone: Treatment of Hirsutism
- HAIR REGROWTH
- Forsythiae Fructus: A Review on its Phytochemistry, Quality Control, Pharmacology and Pharmacokinetics
- Androgen Dependence of Hirsutism, Acne, and Alopecia in Women
- Molecular epidemiology of hypospadias: Review of genetic and environmental risk factors
- Oral spironolactone therapy for female patients with acne, hirsutism or androgenic alopecia
- Hormonal Therapy for Acne
- Follicular delivery of spironolactone via nanostructured lipid carriers for management of alopecia
- Visualising Androgen Receptor Activity in Male and Female Mice
- Androgen excess: Investigations and management
- Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing
- Treatment Options for Hirsutism: A Systematic Review and Network Meta-Analysis
- Dermatology of androgen-related disorders
- Medical treatment of hirsutism
- Androgen metabolism in hirsute patients treated with cyproterone acetate
- New Therapeutic Approach to the Hirsute Patient
- Nutrition Strategy and Life Style in Polycystic Ovary Syndrome—Narrative Review
- Hidradenitis suppurativa: an-androgen-dependent disorder
- Hormonal treatment of acne vulgaris: an update
- Hair: What is New in Diagnosis and Management?
- Biology of Hair Growth
- Steroid 5α-Reductase Inhibitors
- Evidence-based approach to cutaneous hyperandrogenism in women
- Hirsutism: Diagnosis and management
- Androgens Affect the Activity of Human Sebocytes in Culture in a Manner Dependent on the Localization of the Sebaceous Glands and Their Effect Is Antagonized by Spironolactone
- Spironolactone Therapy for Hirsutism in a Hyperandrogenic Woman
- Pharmacologic Therapy of Polycystic Ovary Syndrome